Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

ClinicalTrials.gov ID: NCT00002429

Public ClinicalTrials.gov record NCT00002429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 6:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of HIV RNA Suppression Produced by a Triple Combination Regimen Containing an Enteric Coated Formulation of Didanosine (ddI EC) Administered Once Daily Compared to a Reference Combination Regimen

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study tests a new form of didanosine, ddI EC, a coated pill that passes through the stomach before dissolving. The purpose of this study is to compare the effectiveness of an anti-HIV drug combination that includes ddI EC versus another anti-HIV drug combination.

Study identification

NCT ID
NCT00002429
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 1999
Primary completion
Dec 31, 2000
Completion
Dec 31, 2000
Last update posted
May 3, 2011

1999 – 2001

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Sorra Research Ctr / Med Forum Birmingham Alabama 35203
Body Positive Phoenix Arizona 85016
AIDS Healthcare Foundation Los Angeles California 900276069
San Francisco Gen Hosp San Francisco California 94115
Med Alternatives Fort Lauderdale Florida 33308
County Line Med CtrInc Pembrook Florida 33023
Dr Gerald Pierone Jr Vero Beach Florida 32960
The CORE Ctr Chicago Illinois 60612
Indiana Univ Med Ctr Indianapolis Indiana 462025250
Univ of Kansas School of Medicine Wichita Kansas 672143124
Henry Ford Hosp Detroit Michigan 48202
Dartmouth-Hitchcock Med Ctr Lebanon New Hampshire 03756
NJCRI Newark New Jersey 07103
Infectious Disease Assoc of Central Jersey Somerville New Jersey 08876
Ohio State Univ Hosp Clinic Columbus Ohio 432101228
Anderson Clinical Research Pittsburgh Pennsylvania 15213
Univ of Texas Southwestern Med Ctr of Dallas Dallas Texas 75235
Gathe, Joseph, M.D. Houston Texas 77004
Montrose Clinic Houston Texas 77006
Hampton Roads Med Specialists Hampton Virginia 23666

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2011 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002429 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →